Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the safety and effectiveness of systemic hyperbaric oxygen therapy (HBOT) to treat adults with persistent post-concussive syndrome (PCS) after mild traumatic brain injury (mTBI).
Technology Description:…
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the safety and effectiveness of cyanoacrylate embolization (CAE) with the VenaSeal closure system (Medtronic Inc.) to treat symptomatic varicose veins. This HTA also compares the effectiveness and safety of the VenaSeal closure system with other endovenou…
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of magnetic sphincter augmentation (MSA) with the LINX Reflux Management System (Torax Medical Inc., acquired by Ethicon Inc.) for the treatment of gastroesophageal reflux disease (GERD).
Focus of the Report: This Health Technology Assessment focuses on wide-area transepithelial sampling (WATS) biopsy with 3-dimensional (3D) imaging as an adjunct to or replacement for standard forceps biopsy of the esophagus for detection of Barrett’s esophagus (BE) and esophageal dysplasia, with the goal of reducing the risk of progression to… Focus of the Report: The focus of this Health Technology Assessment is on the use of extracorporeal shock wave therapy (ESWT) as a noninvasive treatment for symptomatic calcific tendinitis of the shoulder when other conservative therapies have failed. Technology Description: ESWT devic… Focus of the Report: This Health Technology Assessment focuses on the efficacy and safety of the CardioMEMS implantable hemodynamic monitor (CM-IHM) (Abbott) as an adjunct to the management of patients with heart failure (HF). Technology Description: The CM-IHM system utilizes an impla… Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of ganglion impar block (GIB) or radiofrequency thermocoagulation (RFT) of the ganglion impar to treat chronic pain in adults with chronic coccydynia. Technology Description:
Focus of the Report: This Health Technology Assessment focuses on anti-infliximab (IFX) antibody (ATI) testing in patients who are undergoing IFX treatment for Crohn disease (CD). This testing is a type of therapeutic drug monitoring (TDM) that is performed to help determine whether ongoing treatment is safe and effective and whether changes … Focus of the Report: This Health Technology Assessment focuses on the use of the Woven EndoBridge (WEB) aneurysm embolization system, an intrasaccular flow disruption device, for the treatment of intracranial aneurysms (IAs). Technology Description: T… Focus of the Report: This Health Technology Assessment focuses on use of bronchial thermoplasty (BT) as an adjunct treatment for severe persistent asthma that remains symptomatic despite medical management with inhaled corticosteroids (ICS) and long-acting beta2 agonists (LABAs). Technology …Wide-Area Transepithelial Sampling Biopsy for Detection of Barrett’s Esophagus/Esophageal Dysplasia
Extracorporeal Shock Wave Therapy for Calcific Tendonitis of the Shoulder
CardioMEMS Implantable Hemodynamic Monitor (Abbott) for Managing Patients With Heart Failure
Ganglion Impar Block or Radiofrequency Thermocoagulation for Treatment of Chronic Coccydynia
Use of Anti-infliximab Antibody Levels to Monitor Infliximab Treatment in Patients With Crohn Disease
Woven EndoBridge Aneurysm Embolization System (MicroVention Inc.) for Treatment of Intracranial Aneurysms
Bronchial Thermoplasty for Treatment of Asthma in Adults